Fig. 1From: Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patientsStudy design. ICI immune checkpoint inhibitor, CT chemotherapy, AIFA Italian Medicines Agency, TA tumor assessment, PD progression disease, C therapy cycle, CTAD sodium citrate, theophylline, adenosine and dipyridamole, EDTA ethylenediamine tetraacetic acid. Created with BioRender.comBack to article page